{"disease":{"id":"uveitic-macular-edema","name":"uveitic macular edema"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05642325","title":"Vamikibart in Participants With Uveitic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT05642312","title":"A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":245,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT04455399","title":"Time Efficiency Comparison of Two IntraVitreal Injection Techniques","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Peregrine Eye and Laser Institute","has_results":false},{"nct_id":"NCT06771271","title":"A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular Edema","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}